
Around 4,000 women with breast cancer could benefit from a new twice-daily pill approved by the NHS.
The National Institute for Health and Care Excellence (Nice) has announced it will now offer eligible women abemaciclib, a drug that reduces the risk of cancer returning once a tumour has been removed.